Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: FDA wants to exclude weight loss drugs from a compounding list

STAT+: FDA wants to exclude weight loss drugs from a compounding list
ShareXFacebook

FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of GLP-1 drugs from Novo Nordisk and Eli Lilly.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

Trump Yanks Surgeon General Nominee, Offers New Option
MedPage Today

Trump Yanks Surgeon General Nominee, Offers New Option

(MedPage Today) -- President Trump says he's nominating Fox News contributor Nicole Saphier, MD, for surgeon general after the path forward for Casey Means, MD, stalled in the Senate over questions about her experience and her stance on vaccines...

Read more →
Advertisement